|
|
Article: Anti-inflammatory doxycycline reduces rosacea lesions.(Dermatologic Therapy)
- Article from:
- Skin & Allergy News
- Article date:
- March 1, 2006
- Author:
CopyrightCOPYRIGHT 2006 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
KAPALUA, HAWAII -- A formulation of doxycycline that is anti-inflammatory without being antibiotic significantly reduced rosacea lesions in two phase III trials, according to Dr. James Q. Del Rosso, the principal investigator.
Dr. Del Rosso, a dermatologist in Las Vegas, reported that CollaGenex Pharmaceuticals Inc., in Newtown, Pa., has already applied to the Food and Drug Administration for an indication in rosacea based on the outcomes.
He gave a general description of the findings at the Winter Clinical Dermatology Conference, Hawaii, and said that data from the trials would be presented at the American Academy of Dermatology meeting this month.
...